Replies to post #10604 on CryoPort Inc (CYRX)

[CYRXorbust]

if/when that goes commercial the results could be explosive


http://www.kitepharma.com/our-research/pipeline/?utm_source=google_um&utm_medium=cpc&utm_content=MAGE%20A3/A6&utm_campaign=Kite%20Work&utm_term=KITE-718

unfortunately still in Phase 1 so a long ways off. Novartis CTL019 Phase 2 results were released in late 2015 and here we are at the cusp of FDA approval ~ 3 yrs later. hopefully in a year from now we will hear wind of positive results of KITE718 in Phase 2 trials which might trigger the FDA to fast track this treatment. Solid Tumor treatment will make CTL0119 look like small potatoes. if CTL019 = $8mm i would imagine solid tumor treatment might generate 20x